Clinical Trial: Seprafilm™ for the Prevention of Intraperitoneal Adhesions and Improved Delivery of Therapy in Women Undergoing Staging and Intraperitoneal Chemotherapy for Advanced Ovarian Cancer

Clinical Trial: Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer

Sponsor and Collaborators

University of British Columbia
Genzyme

Contact

Contact: Jessica McAlpine, MD
604 877-6000
jessica.mcalpine@vch.ca

Principal Investigator
Study Director: Dr. Dianne Miller British Columbia Cancer Agency
Study Director: Mark S Carey, MD University of British Columbia
Study Director: Thomas G Ehlen, MD University of British Columbia
Principal Investigator: Sarah Finlayson, MD University of British Columbia
Study Director: Janice Kwon, MD University of British Columbia
Study Director: Gavin CE Stuart, MD University of British Columbia
Study Director: Anna Tinker, MD British Columbia Cancer Agency
Study Director: Mark Heywood, MD University of British Columbia

ClinicalTrials.gov Identifier

NCT01095367
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs